BPA

3DHISTECH has won the GHP Life Sciences Award – Leading Pioneers in Digital Pathology 2020 & Best Pathology Management Software Solution: CaseManager. Founded by Global Health & Pharma, a global information sharing platform and a multi-disciplinary professional community, the GHP International Life Sciences Awards aim to reward the dedicated innovators within this vital industry who work tirelessly in the background to ensure progressive innovations in medicine, vaccinations, agriculture, infection control, water purification, medical technology and more. In order to learn more…

An independent non-profit alliance of doctors, nurses, healthcare professionals and staff around the world who have united in the wake of the Covid-19 response chapter to share experiences with a view to ending all lockdowns and related damaging measures and to re-establish universal health determinance of psychological and physical wellbeing for all humanity. INTRODUCTION We were told initially that the premise for lockdown was to ‘flatten the curve’ and therefore protect the NHS from being overwhelmed. It is clear that…

Basic Concept of a Diagnostic Management Team Diagnostic Management Team Approach The Diagnostic Management Team (DMT) puts together the diagnostic puzzle and generates a diagnosis or short list of diagnostic options and provides the information to the treating healthcare provider. From: Michael Laposata, M.D., Ph.D.Professor and ChairmanDepartment of PathologyUniversity of Texas Medical BranchGalveston

Manufacturer: Grundium This post is a review (with a video demo) of the whole slide scanning microscope Ocus from Grundium What is Ocus and what does it do?Ocus is a single slide portable whole slide scanning microscope. It enables the scanning and live viewing of one slide at a time. The device connects via wi-fi to a computer or any other device with internet access and a screen and lets you navigate the viewing and scanning process from there. To navigate…

Breast Cancer Research and Treatment Abstract Purpose For optimal management of ductal carcinoma in situ (DCIS), reproducible histopathological assessment is essential to distinguish low-risk from high-risk DCIS. Therefore, we analyzed interrater reliability of histopathological DCIS features and assessed their associations with subsequent ipsilateral invasive breast cancer (iIBC) risk. Methods Using a case-cohort design, reliability was assessed in a population-based, nationwide cohort of 2767 women with screen-detected DCIS diagnosed between 1993 and 2004, treated by breast-conserving surgery with/without radiotherapy (BCS ±…